Mon.Jul 22, 2024

article thumbnail

Drug Advertising, Disease Awareness Misconstrue Patients’ Understanding of Pharmaceutical Benefits

Drug Topics

Researchers aimed to determine the risks and benefits of prescription drug advertising released in tandem with disease awareness programming.

187
187
article thumbnail

STAT+: Express Scripts overcharged postal workers by $45 million, audit says

STAT

Express Scripts, one of the largest pharmacy benefit managers in the country, overcharged U.S. Postal Service employees by a whopping $45 million for their prescription drugs during a recent five-year period, according to a federal audit. The findings are likely to intensify scrutiny of the controversial role played by PBMs in the opaque pharmaceutical pricing system.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Eculizumab-Aagh Receives FDA Approval as Biosimilar to Soliris

Pharmacy Times

Eculizumab-aagh does not have an interchangeable designation, though that could be updated in the future.

FDA 144
article thumbnail

Bird flu that infected 6 Colorado poultry workers is closely related to the virus in cows

STAT

Bird flu snapshot: This is the latest installment in a series of regular updates on H5N1 avian flu that STAT is publishing on Monday mornings. To read future updates, you can also subscribe to STAT’s Morning Rounds newsletter. Public health experts who’ve been following the surprising spillover of H5N1 bird flu into America’s dairy cattle herds now have all eyes on Colorado, waiting to see if a cluster of human cases there might balloon into something bigger.

144
144
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How NVIDIA grew with the healthcare market instead of pushing into it

Pharmaceutical Technology

As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.

137
137
article thumbnail

At a Mass General perfusion lab, a push to make more and more hearts viable for transplant

STAT

It seems like organized chaos. Five lab members move around a room the size of a galley kitchen. On this day, three high school students also squeeze into the medical lab, closely peering at a pig heart barely beating in a box. Tubes connected to the heart from a rhythmic, speaker-like pump push warm red blood cells through its chambers. It looks like a scene out of Frankenstein.

143
143

More Trending

article thumbnail

Q&A: Trans adults face ‘shocking’ risk of cirrhosis, especially alcohol-driven

STAT

People under 45 have been driving an increase in liver-related deaths, especially those caused by alcohol. But a sliver of that young adult population is being hit disproportionately hard by alcohol-associated liver disease: transgender people. Although trans adults make up less than 1% of the United States population, a study published in The American Journal of Gastroenterology last month shows they face double the risk of severe liver disease, and a higher share of cirrhosis from heavy drinki

142
142
article thumbnail

Sinking prices for generic meds a major factor in US shortage crisis: report

Fierce Pharma

As lawmakers and industry groups seek to get a handle on U.S. | As lawmakers and industry groups seek to get a handle on U.S. drug shortages, a new white paper from German market analytics firm QYOBO supports the thesis that disproportionately low prices for generic medicines can make it difficult for drugmakers to keep supplies afloat.

article thumbnail

Opinion: NIDA should beware of funding companies that violate people’s privacy

STAT

In a ground-breaking settlement with the Federal Trade Commission, two online addiction and mental health treatment companies, Monument and Cerebral , admitted to deceptively and widely sharing sensitive personal and health information with third-party advertising platforms including Meta (Facebook) and Google. They aren’t alone. Our research at the Opioid Policy Institute has found more than a dozen other online addiction treatment companies engaging in similar deceptive behavior that co

140
140
article thumbnail

Abridge teams up with Epic, Mayo Clinic to develop gen AI tools for nurses

Fierce Healthcare

Abridge has spent the last six years building generative AI tools to help doctors with medical documentation and is now putting that technology in the hands of hospital nurses. | Abridge has spent the last six years building generative AI tools to help doctors with medical documentation and is now putting that technology in the hands of hospital nurses.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Study Results Indicate Potential Method of Reversing Lupus, Opening Doors to Treatment

Pharmacy Times

The authors note they will continue to investigate treatments for patients with lupus as well as safe and effective methods of delivering these molecules to patients.

123
123
article thumbnail

STAT+: Medicare and Medicaid struggles foreshadow a rocky health insurer earnings season

STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. Express Scripts overcharged your mail carrier Express Scripts, one of the largest pharmacy benefit managers in the country, overcharged U.S. Postal Service employees by a whopping $45 million for their prescription drugs during a recent five-year period, according to an under-the-radar federal audit that my colleague Ed

Insurance 120
article thumbnail

Agilent Technologies lays out $925M to acquire Canadian specialty CDMO Biovectra

Fierce Pharma

After changing hands several times throughout the 2010s, Canadian specialty contract development and manufacturing organization (CDMO) Biovectra has agreed to fly the Agilent flag. | Agilent has revealed that it’s signed a definitive agreement to acquire Biovectra for $925 million through a mix of cash and debt financing. The deal is expected to close this year.

119
119
article thumbnail

STAT+: Pharmalittle: We’re reading about Express Scripts overcharging postal workers, Gilead’s AIDS drug price, and more

STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so familiar routine of online meetings, phone calls, and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup or two of stimulation.

118
118
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

The Impact and Potential of Digital Health Technologies

Pharmacy Times

Innovations are expanding opportunities for care.

117
117
article thumbnail

Applying intercultural intelligence to promote growth in the Middle East

pharmaphorum

Learn how applying intercultural intelligence can promote growth and success in the dynamic and diverse business environment of the Middle East. Gain insights and strategies for effective cross-cultural communication and collaboration.

article thumbnail

FDA Roundup: Soliris Biosimilar, Nonerosive GERD Treatment

Drug Topics

Check out important updates from the FDA from over the past week.

FDA 112
article thumbnail

Study points to route for 'one and done' flu vaccine

pharmaphorum

Scientists at OHSU in the US have developed a universal form of influenza vaccine that they say could protect against all strains of the virus

Vaccines 113
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

FDA Approval Marks Epysqli as Second Soliris Biosimilar

Drug Topics

The approval of eculizumab-aagh offers more treatment options for patients with rare diseases PNH and aHUS.

FDA 112
article thumbnail

Advocates meet with White House to urge inclusion of Adderall, other stimulants in upcoming telehealth prescribing rule

Fierce Healthcare

Advocates meet with White House to urge inclusion of Adderall, other stimulants in upcoming telehealth prescribing rule ebeavins Mon, 07/22/2024 - 14:43

112
112
article thumbnail

NCPA Representative Discusses Role in Influencing PBM Reform

Drug Topics

Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), sat down with Drug Topics to discuss Pharmacy Benefit Managers.

112
112
article thumbnail

Rare Disease Diagnostics: Advancing Orphan Drug Development through Precision Testing

pharmaphorum

Rare Disease Diagnostics: Advancing Orphan Drug Development through Precision Testing Mike.

111
111
article thumbnail

President Biden touts drug pricing achievements as he steps down from re-election campaign

Fierce Pharma

At his vacation home in Delaware, President Joe Biden made the striking announcement that he is dropping out of the 2024 | While President Joe Biden is officially out for the 2024 election, his term has certainly made a mark in the healthcare realm.

111
111
article thumbnail

Experts: Social Determinants of Health Should Be As Important As Clinical Content in Pharmacy Curricula

Pharmacy Times

Educators should prioritize integrating social determinants of health (SDOH) for the next generation of pharmacists.

111
111
article thumbnail

Study finds wearables deliver key insights in heart disease

pharmaphorum

Consumer wearables have shown a benefit when used to monitor treatment responses in patients with atrial fibrillation and heart failure.

111
111
article thumbnail

Pharmacists Are Key to Addressing Flu Vaccine Hesitancy

Pharmacy Times

A strong recommendation from trusted health care professionals can make a difference.

Vaccines 111
article thumbnail

Grünenthal continues US growth push with $250M acquisition of Valinor Pharma

Fierce Pharma

Grünenthal has continued its expansion splurge, | Grünenthal has continued its expansion splurge, acquiring Valinor Pharma and its lone commercial product Movantik (naloxegol), a treatment for opioid-induced constipation (OIC), for $250 million.

111
111
article thumbnail

Grünenthal buys Valinor and constipation drug for $250m

pharmaphorum

Pain medicine specialist Grünenthal has agreed to buy Valinor Pharma for $250m, getting control of Movantik for opioid-induced constipation

110
110
article thumbnail

Bluebird bio's gene therapy fertility support program gets thumbs down from HHS inspector general

Fierce Pharma

The door is closing on bluebird bio’s attempt to secure Medicaid coverage for its fertility support program, which is already offered to patients with commercial insurance who receive its gene ther | The door is closing on bluebird bio’s attempt to secure Medicaid coverage for its fertility support program, which is already offered to patients with commercial insurance who receive its gene therapies.

Insurance 110
article thumbnail

LGBTQ Inclusion Extends to Student Pharmacists Starting Rotations

Pharmacy Times

In the session at the 2024 American Association of Colleges of Pharmacy Annual Meeting, presenters highlighted the importance of fostering inclusion for LGBTQ students.

107
107
article thumbnail

Valneva gets $41m grant to roll out chikungunya vaccine

pharmaphorum

Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life-threatening mosquito-borne disease.

Vaccines 106
article thumbnail

Pharma Pulse 7/22/24: Global Diabetes & Obesity Therapeutics Study, Is There a Correlation Between Medical Debt and Delayed Mental Health Care? & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

105
105
article thumbnail

What to avoid while taking metronidazole

The Checkup by Singlecare

Metronidazole (brand name Flagyl) is a nitroimidazole antibiotic that is most commonly used to treat vaginal infections, certain sexually transmitted diseases (STDs), and gastrointestinal infections such as H. pylori. It can also treat parasitic infections, like giardia, and is frequently used off-label (for a non-FDA-approved use) to help treat Crohn’s disease, bite wounds, and oral infections.

Labelling 105